Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07349498

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation (CORE-HCT): A Prospective Multicenter Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.

Conditions

Timeline

Start date
2026-01-01
Primary completion
2036-06-30
Completion
2036-12-31
First posted
2026-01-16
Last updated
2026-01-16

Locations

16 sites across 1 country: China

Source: ClinicalTrials.gov record NCT07349498. Inclusion in this directory is not an endorsement.